Hereditas最新文献

{"title":"Clinical efficacy of Shaomazhijing granules in the treatment of Tourette's syndrome: a randomized controlled trial.","authors":"Yan-Zhen Wang, Jiang Yang, Xin-Min Han","doi":"10.1186/s41065-025-00462-z","DOIUrl":"10.1186/s41065-025-00462-z","url":null,"abstract":"<p><strong>Objective: </strong>We designed this study to verify the clinical efficacy and safety of Shaomazhijing granules, a Chinese patent medicine, in the treatment of Tourette's syndrome (TS) with liver-yang hyperactivity, liver wind, and phlegm-fire disturbance.</p><p><strong>Methods: </strong>We enrolled a total of 603 children and adolescents aged 5-18 years with TS in this randomized, double-blinded, multicenter study. We randomly assigned participants to a Shaomazhijing granules group, a Tiapride group, or a placebo group in a ratio of approximately 3:1:1, respectively. We evaluated the treatment results using the traditional Chinese medicine (TCM) syndrome quantitative classification scale and also compared the incidence of adverse events among the three groups.</p><p><strong>Results: </strong>The TCM syndrome of all patients improved over time. At week eight of TCM treatment, the overall syndrome score, primary symptoms (muscle tics), and secondary symptoms (emotional and psychological) of patients in the Shaomazhijing granules and tiapride groups showed significant improvements when compared to that of patients in the placebo group. Compared with the tiapride group, the Shaomazhijing granules group showed better improvement in the secondary symptoms (P < 0.05). While the clinical efficacy for primary symptoms of patients in the Shaomazhijing granules was similar (P = 0.969) with that of patients in tiapride groups. The TCM syndrome clinical control rate and the clinically excellent effectiveness rate of the Shaomazhijing granules group (3.45% and 44.51%) and tiapride group (2.86% and 26.67%) were higher than that of the patients in placebo group (1.04% and 12.50%, P < 0.001). Patients in placebo group (11.2%) and Shaomazhijing granules group (13.8%) had significantly lower overall adverse event rates in comparison with those in tiapride group (26.8%, P = 0.002).</p><p><strong>Conclusion: </strong>The clinical efficacy of Shaomazhijing granules is comparable to tiapride in reducing reducing the primary symptoms (muscle tics) of TS. Besides, it showed better efficacy in improving secondary (emotional and psychological) symptoms. Its safety profile is better than tiapride. Based on these results, Shaomazhijing granules can be considered a safe and effective treatment for patients with TS.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"90"},"PeriodicalIF":2.7,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12125844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144191718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identification of immune-related genes and molecular subtypes associated with preeclampsia via bioinformatics analysis and experimental validation.","authors":"Tingting Zhao, Ying Peng","doi":"10.1186/s41065-025-00458-9","DOIUrl":"10.1186/s41065-025-00458-9","url":null,"abstract":"<p><strong>Background: </strong>Preeclampsia (PE) is a pregnancy disorder that occurs after 20 weeks of pregnancy. The objective of this study was to identify potential immune-related biomarkers and molecular subtypes for the treatment of PE.</p><p><strong>Methods: </strong>Three datasets of GSE10588, GSE25906 and GSE48424 were downloaded from the Gene Expression Omnibus (GEO) database. The names of immune-related genes were retrieved from the ImmPort immune database. To screen the differentially expressed immune-related genes, the \"limma\" R package was used. An analysis of logistic regression was used to identify the key genes and a nomogram was constructed using these key genes. These key gene expression profiles were further validated using qRT-PCR. In addition, the landscape of immune cell infiltration was investigated using the CIBERSORTX software. The potential molecular subtypes of PE were also investigated using the \"ConsensusClusterPlus\" R package.</p><p><strong>Results: </strong>The 103 immune-related genes differentially expressed were identified, including 47 up-regulated genes and 56 down-regulated genes. Univariate and multivariate logistic regression analysis was used to screen five key genes, including CCL24, ENG, LCP2, GNAI1 and FLT3. The key genes were strongly associated with immune cell infiltration. Two molecular subtypes (C1 and C2) were identified. Both exhibited distinct levels of immune cell infiltration and gene expression.</p><p><strong>Conclusion: </strong>This study identified five key genes, as well as immune-related subtypes, that could provide potential therapeutic targets and aid in the design of more precise PE immunotherapy.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"89"},"PeriodicalIF":2.7,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12123883/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144181817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Unraveling lncRNA TRG-AS1: a novel biomarker for poor prognosis of gastric cancer and key to regulating malignant behaviors by targeting miR-873-5p.","authors":"Miao Hu, Tiesong Zhang, Yuzhen Ma, Huiling Wang, Suping Hou","doi":"10.1186/s41065-025-00459-8","DOIUrl":"10.1186/s41065-025-00459-8","url":null,"abstract":"<p><strong>Background and study aims: </strong>To alleviate patient stress and advance gastric cancer research, this study aims to investigate the potential association between aberrant expression of TRG-AS1 and gastric cancer, and to examine its potential impact on the biological behaviors of gastric cancer cells.</p><p><strong>Materials and methods: </strong>To find out how TRG-AS1 is expressed in the tissues and cells of gastric cancer, real-time fluorescence quantitative PCR was employed. The connection between TRG-AS1 and pathological features, as well as its prognostic importance, were examined using the Chi-square test and Cox regression analysis. The dual luciferase reporting assay was utilized to confirm the targeting of TRG-AS1 and miR-873-5p. Transwell assay and CCK-8 test were used to identify the roles that TRG-AS1 plays in cell metastasis and proliferation, respectively.</p><p><strong>Results: </strong>Research has revealed a downregulation of TRG-AS1 in the tissues and cells, which is strongly correlated with the differentiation, TNM stage, lymph node metastasis, depth of invasion, and patient survival rate in gastric cancer. The binding sites exists between miR-873-5p and TRG-AS1, and TRG-AS1 has the ability to negatively control miR-873-5p by acting as a competitive endogenous RNA. When TRG-AS1 was overexpressed, the malignant behavioral activity of gastric cancer cells was significantly decreased; however, the inhibitory effect was reversed when miR-873-5p was overexpressed.</p><p><strong>Conclusions: </strong>TRG-AS1 is a potential predictor of poor prognosis in gastric cancer patients and targets miR-873-5p to inhibit the progression of cancer.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"88"},"PeriodicalIF":2.7,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12121179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144181382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"BHLHE40-mediated RGS16 upregulation: a driver propelling gastric cancer progression via ferroptosis suppression.","authors":"Caiyun Guo, Hua Tang, Maifang Ren, Yongli Zhang","doi":"10.1186/s41065-025-00447-y","DOIUrl":"10.1186/s41065-025-00447-y","url":null,"abstract":"<p><strong>Background: </strong>Gastric cancer (GC), a malignant neoplasm that arises from the epithelium of the gastric mucosa, endangers patients' lives and health severely. Regulator of G-protein signaling 16 (RGS16) has been found to be correlated with the malignant progression of various cancers, and BHLHE40 is highly expressed in GC. However, it remains unclear whether there is a regulatory mechanism between the them.</p><p><strong>Methods: </strong>The bioinformatics tools were applied to assess the differentially expressed genes in GC. Next, the expression levels of mRNA and protein were evaluated by qRT-PCR and Western blot. Cellular behaviors were assessed using CCK-8, EdU, Transwell, and flow cytometry assays. Meanwhile, the ferroptosis-related indicators were measured. Subsequently, the xenograft models were set up to estimate the role of RGS16 in vivo. Besides, the interaction between BHLHE40 and RGS16 was determined using ChIP assay and dual-luciferase reporter assay.</p><p><strong>Results: </strong>RGS16 exhibited an upregulated pattern in GC. In addition, silencing RGS16 impeded the proliferation, migration and invasion of GC cells while reinforcing apoptosis and ferroptosis. Moreover, RGS16 boosted the growth of tumors in vivo. Furthermore, BHLHE40 could bind to RGS16 and positively regulate its expression. Overexpression of RGS16 reversed the effects of silencing BHLHE40 on GC cells.</p><p><strong>Conclusion: </strong>BHLHE40 curbed ferroptosis and oxidative stress of GC cells by modulating the expression of RGS16, thereby facilitating the malignant progression of GC.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"87"},"PeriodicalIF":2.7,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12102885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identification and validation of USP15 and CUL2 as ubiquitination related biomarker in chronic obstructive pulmonary disease.","authors":"Shulei Sun, Zhaoxiong Zhang, Haiyan Zhao","doi":"10.1186/s41065-025-00460-1","DOIUrl":"10.1186/s41065-025-00460-1","url":null,"abstract":"<p><strong>Purpose: </strong>Ubiquitination is one of the important epigenetic modifications, influencing the development of various diseases. The objective of this study is to investigate the ubiquitination related genes in chronic obstructive pulmonary disease (COPD).</p><p><strong>Methods: </strong>The gene microarray dataset from COPD patients and ubiquitination related genes were analyzed. Venn diagram analysis was used to intersect differentially expressed genes and ubiquitination related genes. The functional enrichment analysis of Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Set Enrichment Analysis (GSEA) were performed on differentially expressed ubiquitination related genes. Finally, we confirmed the expression of hub genes through qPCR and western blot experiments in clinical COPD patients and cell lines.</p><p><strong>Results: </strong>We identified 2,932 differentially expressed genes and 96 differentially expressed ubiquitination related genes. GO analysis indicated that the differentially expressed ubiquitination related genes were mainly enriched in post-translational protein modification and ubiquitin ligase complex. KEGG analysis showed that ubiquitination related genes were mainly involved in ubiquitin mediated proteolysis and TNF signaling pathway. GSEA analysis suggested that some hub genes are involved in allograft rejection, IL6/JAK/STAT3 signaling and inflammatory response. Our qPCR and western blot experimental results indicate that the expression of USP15 and CUL2 is higher in COPD group compared to the control group, consistent with the bioinformatics analysis.</p><p><strong>Conclusion: </strong>Our bioinformatics analysis and experimental results suggest that USP15 and CUL2 may contribute to the progression of COPD through ubiquitination modification. To our knowledge, this is the first study to demonstrate the involvement of USP15 and CUL2 in COPD. Our results may provide new insights into the diagnosis and treatment of COPD.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"86"},"PeriodicalIF":2.7,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12103031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical significance of LINC01158 in breast cancer and inhibition of proliferation and metastasis of breast cancer cells by regulating miR-711.","authors":"Xiaohe Lan, Zibai Guo, Linmei Lin, Wanqi Lin, Yi Zheng, Yabing Liu","doi":"10.1186/s41065-025-00452-1","DOIUrl":"10.1186/s41065-025-00452-1","url":null,"abstract":"<p><strong>Objective: </strong>Breast cancer (BC) has a poor prognosis due to metastasis and recurrence. LINC01158 is aberrantly expressed in breast cancer. Therefore, we investigated the regulatory mechanism and prognostic value of LINC01158 in BC.</p><p><strong>Methods: </strong>121 patients with BC were enrolled. LINC01158 and miR-711 levels were analyzed by RT-qPCR. Independent predictors of poor BC prognosis were analyzed by multifactorial Cox regression. Kaplan-Meier curves were used to analyze the 5-year survival rate of BC patients. DLR assay verified the relationship between LINC01158 and miR-711 target binding. CCK-8 was used to detect the proliferative capacity of cells. Transwell was used to analyze cell migration and invasion ability.</p><p><strong>Results: </strong>In BC tissues and cell lines, LINC01158 expression was reduced and miR-711 levels were elevated. Low expression of LINC01158 resulted in a shortened overall survival of BC patients. LINC01158 binds to the miR-711 target and negatively correlates with the level of miR-711. Overexpression of LINC01158 decreased miR-711 levels and reduced BC cell proliferation, migration and invasion. In addition, Cox regression results showed that LINC01158 was an independent prognostic factor for BC.</p><p><strong>Conclusion: </strong>LINC01158 may be a prognostic marker for BC. Increasing the expression level of LINC01158 could reduce the expression of miR-711, which could inhibit cell proliferation, migration and invasive behaviors, and has the potential to delay the progression of BC.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"84"},"PeriodicalIF":2.7,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12096782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144127375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hsa_circ_0006837 suppresses gastric cancer cell proliferation, migration, and invasion via the modulation of miR-424-5p.","authors":"Yanxin He, Yeyu Sun, Yinglan Zheng, Yanfang Jiang, Na Li, Wenjie Zhao, Wanhua Ren","doi":"10.1186/s41065-025-00449-w","DOIUrl":"10.1186/s41065-025-00449-w","url":null,"abstract":"<p><strong>Background: </strong>The mechanism by which circRERE (hsa_circ_0006837) modulates the malignant progression of gastric cancer was investigated to identify a novel biomarker and therapeutic target for this disease.</p><p><strong>Methods: </strong>Hsa_circ_0006837 expression in GC tissues and cells was detected by RT-qPCR. Several data analysis methods were used to evaluate the significance of dysregulated hsa_circ_0006837 in GC. The patients were followed up for five years, and survival analysis was conducted using Kaplan-Meier curves. Cox regression was subsequently performed to analyze the risk factors for prognosis. The malignant behaviors of the cells were detected by the CCK-8 and Transwell assays. The relationship between hsa_circ_0006837 and miR-424-5p was assessed by conducting Spearman correlation analysis and verified by dual-luciferase reporter assay.</p><p><strong>Results: </strong>Hsa_circ_0006837 expression decreased in patients with GC, indicating a poorer patient prognosis. In GC cells, hsa_circ_0006837 overexpression suppressed malignant behaviors. Mechanistically, miR-424-5p was identified as a target of hsa_circ_0006837. The overexpression of miR-424-5p partially counteracted the suppressive effects of upregulated hsa_circ_0006837 on the malignant behaviors of GC cells. FBXO21 was identified as a downstream gene of the hsa_circ_0006837/miR-424-5p axis.</p><p><strong>Conclusions: </strong>To summarize, hsa_circ_0006837 is a biomarker for the prognosis of GC. Mechanistically, hsa_circ_0006837 overexpression can modulate the malignant behaviors of GC cells through miR-424-5p.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"85"},"PeriodicalIF":2.7,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144127295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identification of m5C RNA modification-related gene signature for predicting prognosis and immune microenvironment-related characteristics of heart failure.","authors":"Zirui Liu, Rui Feng, Ying Xu, Meili Liu, Haocheng Wang, Yu Lu, Weiqi Wang, Jikai Wang, Cao Zou","doi":"10.1186/s41065-025-00454-z","DOIUrl":"10.1186/s41065-025-00454-z","url":null,"abstract":"<p><strong>Background: </strong>Methylation of RNA is involved in many pathophysiological processes. The roles of N6-methyladenosine (m6A) and N7-methylguanosine (m7G) in heart failure (HF) have been established. However, the impact of 5-methylcytosine (m5C) on HF and its relationship with the immune microenvironment (IME) remains elusive.</p><p><strong>Methods: </strong>GSE141910 (200 HF, 166 NFDs) was used as training cohort. Focusing on 9 identified m5C differently expressed genes (DEGs), random forests (RF), LASSO logistic regression, and SVM-RFE were employed to identify hub genes. ROC curves were plotted to confirm the predictive value in diagnostic model. ScRNA-seq revealed cell-type-specific m5C regulator expression patterns and HF IME. Hub genes were validated using HF rat models after myocardial infarction (MI) through quantitative reverse-transcription PCR (qRT-PCR) and western blot (WB). Consensus clustering algorithms identified two m5C-related HF subtypes. Single-sample gene-set enrichment analysis (ssGSEA) and CIBERSORT deconvolution algorithm analyzed the IME in HF. Finally, we employed WGCNA and PPI network to find m5C associated key genes and their clinical significance in HF subgroups.</p><p><strong>Results: </strong>In HF samples, four m5C regulators (NSUN6, DNMT3A, DNMT3B and ALYREF) were greatly upregulated, while five (NOP2, NSUN3, NSUN7, DNMT1 and TRDMT1) were downregulated compared to NFDs in the training set. ALYREF positively correlated with activated NK cells and monocytes, whereas TRDMT1 and NSUN3 showed inverse correlations with these cells. Four hub genes were identified by machine-learning algorithms and all verified by validation model. Single-cell RNA-seq dataset GSE183852 examined the levels of 13 m5C regulators across 11 different cell types in HF. In vivo experiments including qRT-PCR and WB finally identified NSUN6 as the most remarkable regulator. The diagnostic model demonstrated excellent performance in distinguishing between HF and NFDs (AUC 0.869, 95%CI 0.832-0.906). The two m5C subtypes exhibited distinct modification patterns, immune cell infiltration, immune checkpoints, and HLA gene expression. Additionally, 138 differentially expressed genes were uncovered based on m5C subtypes, and GSEA revealed associations with key pathophysiological mechanisms of HF. By using WGCNA and PPI network, three m5C associated key genes (RPS21, RPL36 and RPS19) were identified significantly influencing cardiac function in clinical practice.</p><p><strong>Conclusion: </strong>HF diagnostic model is developed based on 4 robust m5C RNA modification biomarkers (DNMT3B, NOP2, NSUN6 and DNMT1). Two distinct m5C RNA modification patterns in HF are identified, illustrating different IME characteristics. Our findings underline the significance of m5C regulators in HF, offering new perspectives on HF mechanisms and potential diagnostic and therapeutic strategies.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"83"},"PeriodicalIF":2.7,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12096717/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144127301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy of red ointment in wound cavity repair following non-puerperal mastitis debridement.","authors":"Jiamei Feng, Zheng Chen, Jiaye Sun, Shijun Shao, Lu Xie, Wenchao Qu, Qingqian Gao, Xueqing Wu, Hua Wan","doi":"10.1186/s41065-025-00451-2","DOIUrl":"10.1186/s41065-025-00451-2","url":null,"abstract":"<p><strong>Background: </strong>The objective of this study is to evaluate the efficacy of red ointment, a widely used topical agent in traditional Chinese medicine, in promoting wound cavity repair following debridement for non-puerperal mastitis (NPM).</p><p><strong>Methods: </strong>A prospective, randomized controlled trial was conducted, including 88 patients diagnosed with NPM. Patients were randomly assigned to either the treatment group or the control group. All patients underwent debridement during the acute inflammatory phase. Postoperatively, the treatment group received daily dressing changes using sterile gauze strips infused with red ointment, whereas the control group received sterile gauze strips soaked in rivanol. The effectiveness of treatment was assessed after two weeks by evaluating the total effective rate, wound cavity score, symptom and sign score, laboratory parameters, and adverse events.</p><p><strong>Results: </strong>In the intention to treat analysis, the total effective rate was 90.9% in the red ointment group, which was higher than the 86.4% observed in the rivanol group. In the per protocol analysis, the total effective rate was 97.6% in the red ointment group, exceeding the 92.7% in the rivanol group. Compared with rivanol-treated gauze strips, the use of red ointment gauze strips resulted in a significantly greater reduction in wound cavity volume (p < 0.05), improved local breast symptoms (p < 0.05), and a lower wound cavity score (p < 0.001). Granulation tissue in the red ointment group exhibited a significantly fresher color compared to the rivanol group (p < 0.05). No significant differences were observed between the two groups regarding adverse effects on hepatic and renal function following treatment.</p><p><strong>Conclusion: </strong>The use of red ointment gauze strips for wound cavity filling following NPM debridement demonstrated favorable clinical efficacy and safety, providing a viable option for postoperative drainage management.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"82"},"PeriodicalIF":2.7,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144101771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Novel exosome-associated LncRNA model predicts colorectal cancer prognosis and drug response.","authors":"Chi Zhou, Qian Qiu, Xinyu Liu, Tiantian Zhang, Leilei Liang, Yihang Yuan, Yufo Chen, Weijie Sun","doi":"10.1186/s41065-025-00445-0","DOIUrl":"10.1186/s41065-025-00445-0","url":null,"abstract":"<p><strong>Background: </strong>Exosomes are extracellular vesicles that carry various biological substances and have potential as functional mediators in cancers. However, little is known about special molecules in colorectal cancer (CRC) exosomes and their immunological functions.</p><p><strong>Aims: </strong>Using genomic data from the TCGA-CRC cohort, we constructed a prognostic model based on exosome-related lncRNA for the first time, and the biological role of MIR4713HG in CRC was deeply analyzed.</p><p><strong>Method: </strong>In this study, we downloaded the gene expression data and clinical data of CRC from the TCGA database. The limma package, SVM-REF and univariate Cox analysis were used to screen out core ERG (CERG) in CRC. LASSO and multivariate Cox regression analyses were used to filter out CERG-related LncRNA and construct a risk score. We explored the distribution and expression levels of ERG in immune cell types by scRNA-seq data. xCell was used to calculate the infiltration levels of stromal cells and immune cells in CRC. KM plotter was used for immunotherapy evaluation of core ERG. Next, we further provide colony formation assay, Transwell assay and xenograft models to understand the carcinogenic effect of MIR4713HG.</p><p><strong>Result: </strong>First, 43 differentially expressed ERG and 7 CERG were obtained. We explored the expression and distribution levels of CERG in 9 types of cells by scRNA-seq data. In addition, two key exosome-associated LncRNA (MIR4713HG and ZEB1-AS1) were obtained, and a risk score (EALncRI) was constructed. EALncRI could accurately predict the prognosis of CRC. Based on the EALncRI, we constructed a nomogram that is easy to use in clinical practice, which can more accurately and stably predict the prognosis of CRC patients. Furthermore, EALncRI was significantly correlated with the expression of 5 HLA molecules and 13 immune checkpoint molecules. MIR4713HG showed a good predictive effect in the overall survival of patients with immunotherapy evaluation. Knocking down the expression of MIR4713HG significantly inhibited proliferation and migration, and also impaired subcutaneous tumor growth in nude mice.</p><p><strong>Conclusion: </strong>In this study, a variety of machine learning algorithms were used to construct the EALncRI based on ERG, which can effectively predict the prognosis and distinguish the immune landscape of CRC. More importantly, we conducted an in-depth study on MIR4713HG, which may become an important therapeutic target in CRC.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"79"},"PeriodicalIF":2.7,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12082951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144086151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}